<?xml version='1.0' encoding='utf-8'?>
<document id="28891960"><sentence text="Alterations in Pharmacokinetics of Gemcitabine and Erlotinib by Concurrent Administration of Hyangsayukgunja-Tang, a Gastroprotective Herbal Medicine."><entity charOffset="35-46" id="DDI-PubMed.28891960.s1.e0" text="Gemcitabine" /><entity charOffset="51-60" id="DDI-PubMed.28891960.s1.e1" text="Erlotinib" /><pair ddi="false" e1="DDI-PubMed.28891960.s1.e0" e2="DDI-PubMed.28891960.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28891960.s1.e0" e2="DDI-PubMed.28891960.s1.e1" /></sentence><sentence text="Gemcitabine and erlotinib are the chemotherapeutic agents used in the treatment of various cancers and their combination is being accepted as a first-line treatment of advanced pancreatic cancer"><entity charOffset="0-11" id="DDI-PubMed.28891960.s2.e0" text="Gemcitabine" /><entity charOffset="16-25" id="DDI-PubMed.28891960.s2.e1" text="erlotinib" /><pair ddi="false" e1="DDI-PubMed.28891960.s2.e0" e2="DDI-PubMed.28891960.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28891960.s2.e0" e2="DDI-PubMed.28891960.s2.e1" /></sentence><sentence text=" Hyangsayukgunja-tang (HYT) is a traditional oriental medicine used in various digestive disorders and potentially helpful to treat gastrointestinal adverse effects related to chemotherapy" /><sentence text=" The present study was aimed to evaluate the effect of HYT on the pharmacokinetics of gemcitabine and erlotinib given simultaneously in rats"><entity charOffset="86-97" id="DDI-PubMed.28891960.s4.e0" text="gemcitabine" /><entity charOffset="102-111" id="DDI-PubMed.28891960.s4.e1" text="erlotinib" /><pair ddi="false" e1="DDI-PubMed.28891960.s4.e0" e2="DDI-PubMed.28891960.s4.e0" /><pair ddi="false" e1="DDI-PubMed.28891960.s4.e0" e2="DDI-PubMed.28891960.s4.e1" /></sentence><sentence text=" Rats were pretreated with HYT at an oral dose of 1200 mg/kg/day once daily for a single day or 14 consecutive days" /><sentence text=" Immediately after pretreatment with HYT, gemcitabine and erlotinib were administered by intravenous injection (10 mg/kg) and oral administration (20 mg/kg), respectively"><entity charOffset="37-40" id="DDI-PubMed.28891960.s6.e0" text="HYT" /><entity charOffset="42-53" id="DDI-PubMed.28891960.s6.e1" text="gemcitabine" /><entity charOffset="58-67" id="DDI-PubMed.28891960.s6.e2" text="erlotinib" /><pair ddi="false" e1="DDI-PubMed.28891960.s6.e0" e2="DDI-PubMed.28891960.s6.e0" /><pair ddi="false" e1="DDI-PubMed.28891960.s6.e0" e2="DDI-PubMed.28891960.s6.e1" /><pair ddi="false" e1="DDI-PubMed.28891960.s6.e0" e2="DDI-PubMed.28891960.s6.e2" /><pair ddi="false" e1="DDI-PubMed.28891960.s6.e1" e2="DDI-PubMed.28891960.s6.e1" /><pair ddi="false" e1="DDI-PubMed.28891960.s6.e1" e2="DDI-PubMed.28891960.s6.e2" /></sentence><sentence text=" The effects of HYT on pharmacokinetics of the two drugs were estimated by non-compartmental analysis and pharmacokinetic modeling"><entity charOffset="16-24" id="DDI-PubMed.28891960.s7.e0" text="HYT" /></sentence><sentence text=" The pharmacokinetics of gemcitabine and erlotinib were not altered by single dose HYT pretreatment"><entity charOffset="25-36" id="DDI-PubMed.28891960.s8.e0" text="gemcitabine" /><entity charOffset="41-50" id="DDI-PubMed.28891960.s8.e1" text="erlotinib" /><entity charOffset="83-91" id="DDI-PubMed.28891960.s8.e2" text="HYT" /><pair ddi="false" e1="DDI-PubMed.28891960.s8.e0" e2="DDI-PubMed.28891960.s8.e0" /><pair ddi="false" e1="DDI-PubMed.28891960.s8.e0" e2="DDI-PubMed.28891960.s8.e1" /><pair ddi="false" e1="DDI-PubMed.28891960.s8.e0" e2="DDI-PubMed.28891960.s8.e2" /><pair ddi="false" e1="DDI-PubMed.28891960.s8.e1" e2="DDI-PubMed.28891960.s8.e1" /><pair ddi="false" e1="DDI-PubMed.28891960.s8.e1" e2="DDI-PubMed.28891960.s8.e2" /></sentence><sentence text=" However, the plasma levels of OSI-420 and OSI-413, active metabolites of erlotinib, were significantly decreased in the multiple dose HYT pretreatment group"><entity charOffset="31-38" id="DDI-PubMed.28891960.s9.e0" text="OSI-420" /><entity charOffset="43-50" id="DDI-PubMed.28891960.s9.e1" text="OSI-413" /><entity charOffset="74-83" id="DDI-PubMed.28891960.s9.e2" text="erlotinib" /><entity charOffset="135-143" id="DDI-PubMed.28891960.s9.e3" text="HYT" /><pair ddi="false" e1="DDI-PubMed.28891960.s9.e0" e2="DDI-PubMed.28891960.s9.e0" /><pair ddi="false" e1="DDI-PubMed.28891960.s9.e0" e2="DDI-PubMed.28891960.s9.e1" /><pair ddi="false" e1="DDI-PubMed.28891960.s9.e0" e2="DDI-PubMed.28891960.s9.e2" /><pair ddi="false" e1="DDI-PubMed.28891960.s9.e0" e2="DDI-PubMed.28891960.s9.e3" /><pair ddi="false" e1="DDI-PubMed.28891960.s9.e1" e2="DDI-PubMed.28891960.s9.e1" /><pair ddi="false" e1="DDI-PubMed.28891960.s9.e1" e2="DDI-PubMed.28891960.s9.e2" /><pair ddi="false" e1="DDI-PubMed.28891960.s9.e1" e2="DDI-PubMed.28891960.s9.e3" /><pair ddi="false" e1="DDI-PubMed.28891960.s9.e2" e2="DDI-PubMed.28891960.s9.e2" /><pair ddi="false" e1="DDI-PubMed.28891960.s9.e2" e2="DDI-PubMed.28891960.s9.e3" /></sentence><sentence text=" The pharmacokinetic model estimated increased systemic clearances of OSI-420 and OSI-413 by multiple doses of HYT"><entity charOffset="70-77" id="DDI-PubMed.28891960.s10.e0" text="OSI-420" /><entity charOffset="111-117" id="DDI-PubMed.28891960.s10.e1" text="HYT" /><pair ddi="false" e1="DDI-PubMed.28891960.s10.e0" e2="DDI-PubMed.28891960.s10.e0" /><pair ddi="false" e1="DDI-PubMed.28891960.s10.e0" e2="DDI-PubMed.28891960.s10.e1" /></sentence><sentence text=" These data suggest that HYT may affect the elimination of OSI-420 and OSI-413"><entity charOffset="59-66" id="DDI-PubMed.28891960.s11.e0" text="OSI-420" /><entity charOffset="71-78" id="DDI-PubMed.28891960.s11.e1" text="OSI-413" /><entity charOffset="25-31" id="DDI-PubMed.28891960.s11.e2" text="HYT" /><pair ddi="false" e1="DDI-PubMed.28891960.s11.e2" e2="DDI-PubMed.28891960.s11.e2" /><pair ddi="false" e1="DDI-PubMed.28891960.s11.e2" e2="DDI-PubMed.28891960.s11.e0" /><pair ddi="false" e1="DDI-PubMed.28891960.s11.e2" e2="DDI-PubMed.28891960.s11.e1" /><pair ddi="false" e1="DDI-PubMed.28891960.s11.e0" e2="DDI-PubMed.28891960.s11.e0" /><pair ddi="false" e1="DDI-PubMed.28891960.s11.e0" e2="DDI-PubMed.28891960.s11.e1" /></sentence><sentence text="" /></document>